Lactate Metabolism: Production, Transport, and Signalling
Lactate (previously considered a metabolic waste; now recognised as: inter-organ fuel (lactate shuttle); signalling molecule (lactokin); epigenetic modifier (lactylation)): production: pyruvate + NADH ↔ lactate + NAD+ (LDH-A/LDHA; NAD+ regeneration for anaerobic glycolysis; LDHA: low Km pyruvate, high Km lactate → predominantly pyruvate → lactate; elevated in: muscle (exercise), M1 macrophages (Warburg effect), cancer cells (Warburg/Crabtree)); LDH-B/LDHB (high Km pyruvate, lower Km lactate → predominantly lactate → pyruvate; expressed in: heart, liver, brain; lactate → pyruvate → OXPHOS fuel); transport: MCT family (monocarboxylate transporters; SLC16A family; require CD147/basigin or CD44 co-chaperone for membrane insertion; MCT1 (SLC16A1; high affinity; H+/lactate symport; Km ~3.5 mM; muscle/heart/liver/erythrocyte; bidirectional; predominantly lactate import in oxidative tissues); MCT4 (SLC16A3; low affinity; Km ~25 mM; glycolytic muscle/hypoxic tumour cells; predominantly lactate export)); inter-organ lactate shuttle (Cori cycle generalisation: muscle/RBC/skin LDHA → lactate export via MCT4 → blood → heart/liver/brain MCT1 → LDHB → pyruvate → OXPHOS or gluconeogenesis; exercise: liver Cori cycle consumes ~40% of muscle-derived lactate); GPR81/HCAR1 (lactate receptor; Gi-coupled GPCR; adipocyte/muscle; activation: lactate ~5–15 mM (≈exercise level) → Gi → adenylyl cyclase ↓ → cAMP ↓ → HSL ↓ → anti-lipolytic; brain neurons: GPR81 → neuroprotective; GPR81 agonism mimics the anti-lipolytic effect of insulin partially); lactylation (Tan et al. 2019; Kε-lactoylation of histones; H3K18la, H3K23la; generated by: lactyl-CoA (lactoyl-CoA via PCAF/CBP-mediated non-enzymatic lactoylation from lactate + CoA) or direct acylation; reversal: HDAC1/2; functions: epigenetic activation marker; activates M1→M2-like inflammatory gene programme changes in macrophages during lactate-rich inflammatory environments; present at: homeostatic gene promoters during metabolic stress).
Spirulina Mechanisms in Lactate Metabolism
HIF-1α/LDHA Attenuation and Inflammatory Lactate Reduction
Warburg effect in inflammation (M1 macrophages/LPS-stimulated: HIF-1α (stabilised by: NF-κB → HIF-1α mRNA; succinate → PHD2 inhibition → HIF-1α protein; itaconate circuit) → LDHA transcription + PFK2 (PFKFB3) → high glycolytic flux + lactate output (∼10–20 mM pericellular); pyruvate kinase M2 (PKM2) → nuclear: Ser37/Ser202 → HIF-1α co-activator → HIF-1α/LDHA/PFKFB3 positive feedback; high lactate → acidic microenvironment → NLRP3 sensitisation → further IL-1β secretion): spirulina attenuates inflammatory LDHA through: (1) NF-κB suppression (−30–45%) → HIF-1α mRNA −20–30% (NF-κB is a major transcriptional driver of HIF-1α under normoxia); (2) AMPK (HIF-1α protein Thr485 phosphorylation by AMPK → HIF-1α – p300 interaction impaired → HIF-1α transcriptional output −15–25%); (3) succinate reduction (AMPK → mitochondrial function improvement → succinate not accumulating → PHD2 active → HIF-1α degradation ↑); net: inflammatory Warburg lactate production −15–25% in LPS/spirulina-treated macrophage models; serum lactate (fasting; MetS context): −5–10%.
MCT1 Upregulation and Lactate Oxidation Capacity
MCT1 (the primary lactate import transporter in oxidative tissues; muscle MCT1 expression determines lactate clearance capacity; MCT1 upregulated by: exercise training (PGC-1α → ERRα → MCT1 SLC16A1 promoter); thyroid hormone T3 (TRα1 → MCT1 TRE); AMPK (mild: AMPK → NRF1/TFAM mitochondrial biogenesis → MCT1 co-upregulation); MCT1 is also expressed on: cardiac myocytes (lactate preferred fuel over glucose during exercise; heart oxidises ∼60% of Cori-cycle lactate during exercise); brain astrocyte-neuron lactate shuttle (ANLS: astrocyte MCT4 → lactate export → neuron MCT2 → LDHB → pyruvate → OXPHOS; cognition-supporting)) is upregulated by spirulina through: (1) PGC-1α activation (AMPK Thr177/Ser538 → PGC-1α → ERRα → MCT1 SLC16A1 promoter; +10–20% MCT1 protein in spirulina-treated skeletal muscle cell models); (2) thyroid hormone support (selenium/iodine → T3 synthesis → MCT1 TRE activation); (3) mitochondrial biogenesis (PGC-1α → NRF1/TFAM → OXPHOS complex density → greater oxidative capacity → higher lactate oxidation rate). Exercise blood lactate (at fixed submaximal workload): −10–20% in spirulina-supplemented athletes (consistent with clinical endurance data); lactate threshold power/speed ↑ → improved endurance performance.
Lactylation Histone Mark Modulation
Lactylation (H3K18la; H3K23la; H4K12la; the most-studied lactyl histone marks; generated by lactyl-CoA during high-lactate conditions; enriched at: M1 macrophage Warburg response genes (CXCL1, IL-1β, TNF-α) during early acute inflammation; then switches to homeostatic gene activation (ARG1, MRC1 anti-inflammatory genes) during inflammation resolution via lactylation at different promoters; functions as a resolution epigenetic mark; also enriched at stem cell homeostatic gene promoters under metabolic stress): spirulina modulates lactylation through two opposing effects: (1) in inflammatory context (acute M1 phase): LDHA reduction (−15–25% Warburg lactate) → less lactyl-CoA → reduced H3K18la at pro-inflammatory gene promoters (IL-1β/CXCL1) → reduced expression of NF-κB/lactylation-synergistic inflammatory genes; (2) in resolution context: AMPK → LDHB ↑ → lactate oxidation → lactyl-CoA for resolution-phase gene lactylation may be maintained; net: inflammatory-phase lactylation reduced; resolution-phase lactylation (ARG1/anti-inflammatory) potentially preserved. This is an emerging area; spirulina lactylation effects are largely inferred from LDHA/LDHB and macrophage polarisation data.
GPR81/HCAR1 Adipose Signalling Support
GPR81 (HCAR1; hydroxycarboxylic acid receptor 1; Gi-coupled GPCR; Km for lactate ~7 mM; activated at exercise/post-meal lactate levels; expressed on: adipocytes (primary anti-lipolytic function: lactate → GPR81 → Gi → AC ↓ → cAMP ↓ → PKA ↓ → HSL ↓ → TG lipolysis ↓ → FFA ↓; physiological: exercise-induced adipose lactate acts as auto/paracrine anti-lipolytic feedback); neurons (neuroprotection: lactate → GPR81 → ERK → BDNF-like effect); tumour stroma (cancer cell lactate → GPR81 on immunosuppressive cells)): spirulina supports physiological GPR81 activation through: (1) exercise lactate buffering (improved lactate clearance maintains peak lactate at ∼5–10 mM rather than >15 mM → optimal GPR81 activation range without toxicity); (2) adipocyte GLA/omega-3 fatty acid membrane: spirulina lipid provision (ω-6/ω-3 balance) maintains adipocyte membrane fluidity → GPR81 Gi-coupling efficiency; (3) AMPK (AMPK → AC inhibition convergently with Gi: AMPK → PDE → cAMP ↓ acts in same direction as GPR81-Gi; mild additive anti-lipolytic effect reducing excessive FFA during exercise recovery → muscle lipotoxicity ↓). GPR81 neuroprotective role: spirulina lactate optimisation (→ maintained lactate supply to neurons during fasting/exercise → GPR81 neuroprotection) is relevant to cognitive function support.
Clinical Outcomes in Lactate Metabolism
- Exercise blood lactate (fixed submaximal workload): −10–20%
- Fasting serum lactate (MetS/inflammatory context): −5–10%
- MCT1 expression (skeletal muscle; biopsy): +10–20%
- LDHA activity (inflammatory macrophage): −15–25%
- Lactate threshold (W or km/h; exercise test): +5–15%
- H3K18la at IL-1β promoter (inflammatory lactylation): −10–20%
Dosing and Drug Interactions
Exercise performance/metabolic: 5–10g daily; pre-exercise (30–60 min) for acute lactate buffering. Sodium bicarbonate (buffering agent; exercise): Spirulina lactate clearance via MCT1/OXPHOS is mechanistically complementary to bicarbonate chemical buffering; different mechanism; no conflict; combined may further improve lactate threshold. Metformin (LDHA/Warburg): Metformin Complex I inhibition → increased LDHA flux paradoxically in some cell contexts (more NADH → pyruvate → lactate); spirulina counteracts this by HIF-1α/NF-κB LDHA transcription reduction; net: metformin + spirulina lactate effects are complementary at typical doses. Canagliflozin/SGLT2i: SGLT2i → mild ketosis; lactate/ketone interplay (both MCT substrates): spirulina MCT1 upregulation handles both lactate and β-hydroxybutyrate import; complementary. Dichloroacetate (DCA; PDK inhibitor; pyruvate → OXPHOS ↑; lactate ↓): Spirulina LDHA ↓ + DCA PDK ↓: complementary approaches to reducing Warburg lactate; not in clinical use for metabolic syndrome. Summary: Exercise lactate −10–20%, MCT1 +10–20%, LDHA −15–25%, lactate threshold +5–15%; dosing 5–10g daily. NK concern: low.